Thrombolysis in antiphospholipid syndrome: Current hematologic perspectives

Current Rheumatology Reports

Volumn 10, Issue 1, 2008, Pages 62-66

  McNall Knapp, René Y ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); APC PROTEIN; BETA2 GLYCOPROTEIN 1; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8 INHIBITOR; HEPARIN; LA ANTIBODY; LIPOCORTIN 5; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; SERINE PROTEINASE INHIBITOR; THROMBIN; THROMBOMODULIN;

ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; BLOOD CLOT LYSIS; DRUG PROTEIN BINDING; FAMILY HISTORY; FETUS WASTAGE; GENETIC POLYMORPHISM; HEMOSTASIS; HEREDITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; PARTIAL THROMBOPLASTIN TIME; PROTEIN BLOOD LEVEL; REVIEW; RISK FACTOR; THROMBOGENESIS; THROMBOGENICITY; THROMBOPHILIA; THROMBOSIS; BLOOD; GENETICS; IMMUNOLOGY; PATHOPHYSIOLOGY;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; HEMOSTASIS; HUMANS; THROMBOPHILIA; THROMBOSIS;

EID: 44949129877     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-008-0011-z     Document Type: Review

References (26)

1. Bevers EM, Galli M: Beta 2-glycoprotein I for binding of anticardiolipin antibodies to cardiolipin. Lancet 1990, 336:952-953.
2. Galli M, Comfurius P, Maassen C, et al.: Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990, 335:1544-1547.
3. de Laat HB, Derksen RH, de Groot PG: Beta2-glycoprotein I, the playmaker of the antiphospholipid syndrome. Clin Immunol 2004, 112:161-168.
4. Salobir B, Sabovic M, Hojnik M, et al.: Anti-beta 2-glycoprotein I antibodies of IgM class are linked to thrombotic disorders in young women without autoimmune disease. Immunobiology 2007, 212:193-199.
5. Sodin-Semrl S, Rozman B: beta(2)-Glycoprotein I and its clinical significance: From gene sequence to protein levels. Autoimmun Rev 2007, 6:547-552.
6. Galli M, Borrelli G, Jacobsen EM, et al.: Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study. Blood 2007, 110:1178-1183.
7. de LB, Wu XX, van LM, et al.: Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5. Blood 2007, 109:1490-1494.
8. Esmon NL, Safa O, Smirnov MD, Esmon CT: Antiphospholipid antibodies and the protein C pathway. J Autoimmun 2000, 15:221-225.
9. Sanmarco M, Gayet S, Alessi MC, et al.: Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies. Thromb Haemost 2007, 97:949-954.
10. Bizzaro N, Ghirardello A, Zampieri S, et al.: Anti-prothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: a 15-year longitudinal study. J Thromb Haemost 2007, 5:1158-1164.
11. Lin WS, Chen PC, Yang CD, et al.: Some antiphospholipid antibodies recognize conformational epitopes shared by beta2-glycoprotein I and the homologous catalytic domains of several serine proteases. Arthritis Rheum 2007 56:1638-1647.
12. Wasserman A, Neisser A, Bruck C: Eine serodiagnostiche reaction bei syphilis. Dtsch Mxd Wochensehr 1906, 32:745-746.
13. Triplett DA: Antiphospholipid antibodies. Clin Adv Hematol Oncol 2003, 1:726-730.
14. Cederholm A, Frostegard J: Annexin A5 as a novel player in prevention of atherothrombosis in SLE and in the general population. Ann N Y Acad Sci 2007, 1108:96-103.
15. Lu CS, Horizon AA, Hwang KK, et al.: Identification of polyclonal and monoclonal antibodies against tissue plasminogen activator in the antiphospholipid syndrome. Arthritis Rheum 2005, 52:4018-4027.
16. Safa O, Esmon CT, Esmon NL: Inhibition of APC anticoagulant activity on oxidized phospholipid by anti-{beta}2-glycoprotein I monoclonal antibodies. Blood 2005, 106:1629-1635.
17. Regnault V, Boehlen F, Ozsahin H, et al.: Anti-protein S antibodies following a varicella infection: detection, characterization and influence on thrombin generation. J Thromb Haemost 2005, 3:1243-1249.
18. Guermazi S, Regnault V, Gorgi Y, et al.: Further evidence for the presence of anti-protein S autoantibodies in patients with systemic lupus erythematosus. Blood Coagul Fibrinolysis 2000, 11:491-498.
19. Bardin N, Alessi MC, Dignat-George F, et al.: Does the anti-prothrombin antibodies measurement provide additional information in patients with thrombosis? Immunobiology 2007, 212:557-565.
20. Pierangeli SS, Girardi G, Vega-Ostertag M, et al.: Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia. Arthritis Rheum 2005, 52:2120-2124.
21. Romay-Penabad Z, Liu XX, Montiel-Manzano G, et al.: C5a receptor-deficient mice are protected from thrombophilia and endothelial cell activation induced by some antiphospholipid antibodies. Ann N Y Acad Sci 2007, 1108:554-566.
22. O'Neil KM: Role of complement in antiphospholipid antibody-mediated thrombosis. Curr Rheumatol Rep 2007, 9:205-211.
23. O'Neil KM, Kershen L, Madduri D, Merrill JT: In vitro complement activation by anticardiolipin antibodies predicts coagulopathy [abstract]. Arthritis Rheum 2005, 52:S251.
24. Martinelli I, Mannucci PM, De Stefano V, et al.: Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood 1998, 92:2353-2358.
25. Teruya J, West AG, Suell MN: Lupus anticoagulant assays: questions answered and to be answered. Arch Pathol Lab Med 2007, 131:885-889.
26. Miyakis S, Lockshin MD, Atsumi T, et al.: International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006, 4:295-306.